Skip to main content
Liver Disease
resource center
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
Commentary
Disease State Directory
FDA Alerts
Pearls
Podcasts
Polls
Q&As
Quizzes
Research Summaries
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Case Report Templates
FAQ
Advertising With Consultant360
Search
Login
Menu
Menu
Main navigation
Home
Featured Diseases & Conditions
COVID-19
Depression Care 360
HIV Management
HIV Prevention
Pediatric Influenza
Psoriatic Arthritis
Resources
Commentary
Disease State Directory
FDA Alerts
Pearls
Podcasts
Polls
Q&As
Quizzes
Research Summaries
Slideshows
Videos
Events & Education
Consultant360's Practical Updates in Primary Care
CME
Publication
About Consultant
Consultant Current Issue
Consultant Early View
Consultant Archive
Author Guidelines
Case Report Templates
FAQ
Advertising With Consultant360
Liver Disease
Resource Center
News
Research Summaries
Resources
FDA Alerts
From the Journal
Insights
Podcasts
Q&As
Videos
Interactive
Polls
Quizzes
Events & Education
AASLD: The Liver Meeting
FDA Alerts
Liver Disease
Liver Disease
FDA Expands Approved Use of Stivarga
04/27/2017
The FDA has approved the first new option for the treatment of liver cancer, specifically hepatocellular carcinoma, in nearly 10 years.
04/27/2017